Shao Minghai, Ye Chaoyang, Bayliss George, Zhuang Shougang
Department of Nephrology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Department of Medicine, Rhode Island Hospital and Alpert Medical School, Brown University, Providence, RI, United States.
Front Pharmacol. 2021 Nov 4;12:774414. doi: 10.3389/fphar.2021.774414. eCollection 2021.
The clinical and experimental study into the effects of Chinese herbal medicines on chronic kidney disease has evolved over the past 40 years with new insight into their mechanism and evidence of their clinical effects. Among the many traditional Chinese herbs examined in chronic renal disease, five were found to have evidence of sufficient clinical efficacy, high frequency of use, and well-studied mechanism. They are: and , and its components (tanshinone II A, salvianolic acid A and B); and its monomer ; and its components (triptolide, tripterygium glycosides); Kudzu root and its monomer . These Chinese herbal medications have pharmaceutical effects against fibrosis, inflammation and oxidative stress and also promote renal repair and regeneration. This article reviews their clinical efficacy, anti-fibrotic effects in animal models, and molecular mechanism of action.
在过去40年里,关于中草药对慢性肾脏病影响的临床和实验研究不断发展,对其作用机制有了新的认识,并积累了临床疗效证据。在众多用于慢性肾脏病研究的传统中草药中,有五种被发现具有充分的临床疗效证据、高使用频率以及深入研究的作用机制。它们是:[此处原文缺失具体草药名称]和[此处原文缺失具体草药名称];[此处原文缺失具体草药名称]及其成分(丹参酮IIA、丹酚酸A和B);[此处原文缺失具体草药名称]及其单体[此处原文缺失具体单体名称];[此处原文缺失具体草药名称]及其成分(雷公藤内酯醇、雷公藤多苷);葛根及其单体[此处原文缺失具体单体名称]。这些中草药具有抗纤维化、抗炎和抗氧化应激作用,还能促进肾脏修复和再生。本文综述了它们的临床疗效、在动物模型中的抗纤维化作用以及分子作用机制。
Front Pharmacol. 2021-11-4
J Ethnopharmacol. 2017-7-12
J Ethnopharmacol. 2014-8-7
Zhongguo Zhong Yao Za Zhi. 2012-8
Clin Exp Pharmacol Physiol. 2016-2
Front Pharmacol. 2024-9-20
Chin J Integr Med. 2025-2
Front Pharmacol. 2024-7-31
J Tradit Complement Med. 2023-5-31
Comb Chem High Throughput Screen. 2024
Front Pharmacol. 2021-3-29
Diabetes Metab Syndr Obes. 2020-10-23
Int Immunopharmacol. 2020-12